SUBSCRIBE
SUBSCRIBE
News   Business

Nisshin Kyorin Pharmaceutical, Yakult To Form Marketing Alliance For 5-HT3 Receptor Antagonist

October 19, 2005 | 
1 min read
Nisshin Kyorin Pharmaceutical announced on August 24 that it has concluded a cooperative sales agreement with Yakult Honsha for "Sinseron Tablet 8 mg," a serotonin 5-HT3 receptor antagonist with antiemetic property.
Alliances
MORE ON THIS TOPIC
Vector Illustration Of Athletes Running On Race Track
Weight loss
Lilly takes oral obesity race abroad with UK launch of Foundayo
August 25, 2026
 · 
1 min read
 · 
Tristan Manalac
Salary negotiation, pay raise discussion or wages and benefit agreement, business deal or merger and acquisition concept, business people handshake on pile of money banknote after finish agreement.
Obesity
Roche bets up to $2.3B in Hanmi pact for next-gen weight loss drug
August 24, 2026
 · 
2 min read
 · 
Tristan Manalac
Time on the hourglass stopped. Clock on table. Pause in business, collapse.
Pipeline
Boehringer Ingelheim suspends early study for pill candidate after ‘safety event’
August 24, 2026
 · 
1 min read
 · 
Tristan Manalac
The factor that changes everything. A critical break. A sudden change in plans. A threat and a danger. Recover from the blow and get back on course. Severe stress. Withstand the blow.
Duchenne muscular dystrophy
Capricor investor calls for change as company awaits decision on Duchenne candidate
August 21, 2026
 · 
3 min read
 · 
Heather McKenzie